Management of Bronchospasm and Laryngospasm: Guideline-Based Algorithms
For laryngospasm, immediately apply continuous positive airway pressure with 100% oxygen while ensuring airway patency, followed by Larson's manoeuvre, and escalate to propofol 1-2 mg/kg IV, then suxamethonium 1 mg/kg IV if hypoxia worsens; for bronchospasm in anaphylaxis, administer adrenaline 50 μg IV (adult) or 1 μg/kg IV (pediatric) as the primary intervention, with salbutamol infusion for persistent cases. 1, 2
LARYNGOSPASM MANAGEMENT ALGORITHM
Prevention Strategies
The risk of laryngospasm peaks during lighter planes of anesthesia 1. Extubate either deeply anesthetized or fully awake—avoid the intermediate stage. Perform suction under direct vision while deeply anesthetized, ensuring the upper airway is clear of debris, then avoid further stimulation until the patient is awake 1.
Topical lidocaine sprayed on vocal cords at induction reduces laryngospasm risk following short procedures 1. Sevoflurane and propofol are the least irritant anesthetic agents 1. Additional preventive adjuncts include IV lidocaine, magnesium, and ketamine 1.
Treatment Algorithm (Adults and Pediatrics)
Step 1: Call for help 1
Step 2: Apply continuous positive airway pressure (CPAP) with 100% oxygen using reservoir bag and facemask while ensuring upper airway patency. Avoid unnecessary upper airway stimulation 1.
Step 3: Larson's manoeuvre - Place the middle finger of each hand in the 'laryngospasm notch' between the posterior border of the mandible and mastoid process while displacing the mandible forward in jaw thrust. Apply deep pressure at this point 1.
Step 4: If laryngospasm persists and/or oxygen saturation is falling:
- Propofol 1-2 mg/kg IV 1
- Low doses may be effective in early laryngospasm
- Larger doses needed for severe laryngospasm or total cord closure
Step 5: Suxamethonium 1 mg/kg IV for worsening hypoxia with continuing severe laryngospasm and total cord closure 1. This provides cord relaxation, permitting ventilation, re-oxygenation, and intubation if necessary.
Step 6: Alternative routes if no IV access:
Step 7: Atropine may be required to treat bradycardia 1.
Step 8: In extremis, consider surgical airway 1.
Critical Pitfall: Post-Obstructive Pulmonary Edema
If unrelieved, laryngospasm can progress to post-obstructive pulmonary edema (>50% of cases), hypoxic cardiac arrest, and death 1. This presents with dyspnea, agitation, cough, pink frothy sputum, and low oxygen saturations 1. It occurs in 0.1% of all general anesthetics, more commonly in young muscular adults (male:female ratio 4:1) 1.
BRONCHOSPASM MANAGEMENT ALGORITHM
In Context of Anaphylaxis (Most Critical Scenario)
Immediate Management - ABC Approach 2:
Step 1: Remove all potential causative agents (IV colloids, latex, chlorhexidine) and maintain anesthesia with inhalational agent if necessary 2.
Step 2: Call for help and note the time 2.
Step 3: Maintain airway and administer 100% oxygen. Intubate and ventilate with oxygen if necessary 2.
Step 4: Elevate patient's legs if hypotensive 2.
Step 5: Administer adrenaline IV immediately 2:
Adult Dosing:
- Initial dose: 50 μg IV (0.5 ml of 1:10,000 solution) 2
- Several doses may be required for severe hypotension or bronchospasm
- Consider adrenaline infusion if multiple doses required (short half-life)
Pediatric Dosing (IV):
- Prepare 1 ml of 1:10,000 adrenaline per 10 kg body weight 2
- Titrate starting with 1 μg/kg (one-tenth of syringe contents) 2
- Children often respond to as little as 1 μg/kg
- Further dilution may be needed in smaller children
Pediatric Dosing (IM if no IV access):
12 years: 500 μg IM (0.5 ml of 1:1000) 2
- 6-12 years: 300 μg IM (0.3 ml of 1:1000) 2
- Up to 6 years: 150 μg IM (0.15 ml of 1:1000) 2
Step 6: Administer saline 0.9% or lactated Ringer's at high rate via large-gauge IV cannula (large volumes may be required) 2.
Secondary Management for Persistent Bronchospasm
Step 7: Administer chlorphenamine 2:
- Adults: 10 mg IV
- 6-12 years: 5-10 mg IV
- 6 months-6 years: 2.5-5 mg IV
- <6 months: 250 μg/kg IV
Step 8: Administer hydrocortisone 2:
- Adults: 200 mg IV
- 6-12 years: 100 mg IV
- 6 months-6 years: 50 mg IV
- <6 months: 25 mg IV
Step 9: For persistent bronchospasm despite adrenaline:
- IV salbutamol infusion 2
- Metered-dose inhaler via breathing-system connector if available 2
- Consider IV aminophylline or magnesium sulfate 2
Step 10: Alternative vasopressor (e.g., metaraminol) if blood pressure does not recover despite adrenaline infusion 2.
Step 11: Transfer to Critical Care area 2.
Key Distinction: Bronchospasm vs. Laryngospasm
Bronchospasm presents with expiratory wheeze, prolonged exhalation, or complete silence on auscultation in severe cases, with decreased pulmonary compliance and falling oxygen saturation 3. Laryngospasm presents with inspiratory 'crowing' sound, suprasternal recession ('tracheal tug'), and paradoxical chest/abdomen movements; complete obstruction is silent 1.
Critical Pitfall: Exclude Other Causes
Before treating as primary bronchospasm or laryngospasm, exclude misplaced tracheal tube, equipment failure, airway irritation, endotracheal tube problems, and aspiration of gastric contents 2, 3. Consider laryngospasm and bronchospasm as differential diagnoses when optimizing ventilation 4.
Pediatric-Specific Considerations
Children have higher incidence of laryngospasm (17.4/1000 vs 8.7/1000 in general population) 5, 6. Anesthesia administered by pediatric anesthesiologists is associated with lower incidence 5. IV anesthesia has lower incidence than inhalational anesthesia 5. In pediatric studies, 38% responded to airway repositioning and CPAP alone, 47.6% required muscle relaxants, and 23.8% required intubation 6.